Jackson Hole Capital Partners, LLC Astrazeneca PLC Transaction History

Jackson Hole Capital Partners, LLC

  • $470 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$54.21 - $70.44 $174,556 - $226,816
3,220 New
3,220 $218,000
Q2 2022

Jul 27, 2022
SELL
$59.26 - $71.14 $7,703 - $9,248
-130 Reduced 3.88%
3,220 $213,000
Q1 2022

May 09, 2022
BUY
$55.72 - $67.12 $186,662 - $224,852
3,350 New
3,350 $222,000

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jackson Hole Capital Partners, LLC Portfolio

Follow Jackson Hole Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email